ProCore Advisors’s Astera Labs ALAB Stock Holding History

ProCore Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Buy	+972	New	+$258K	0.58%	36

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CIA

Capital Impact Advisors Boston, Massachusetts $1.78B AUM 56.11% 1-Year Est. Return

VAM

Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return

ProCore Advisors's ALAB Position: Q2 2026 in Review

ProCore Advisors opened a new position in Astera Labs (ALAB) in Q2 2026: 972 shares worth $470K. The stake represents 0.58% of the portfolio and ranks #36 among its holdings.

520 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

ProCore Advisors held 972 shares of Astera Labs worth $470K as of Q2 2026.
Astera Labs was a new ProCore Advisors position in Q2 2026.
Astera Labs made up 0.58% of ProCore Advisors's portfolio in Q2 2026, its #36 holding.
520 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on ProCore Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.